Influence of COVID-19 on Chemotherapy in Cancer Patient

DOI Web Site 19 References
  • Nakagawa Yukinori
    Department of Pharmacy, Organization of Occupational Health and Safety Wakayama Rosai Hospital
  • Okada Masaya
    Department of Pharmacy, Organization of Occupational Health and Safety Wakayama Rosai Hospital
  • Miyake Miyuki
    Department of Pharmacy, Organization of Occupational Health and Safety Wakayama Rosai Hospital
  • Omoto Naoko
    Department of Pharmacy, Organization of Occupational Health and Safety Wakayama Rosai Hospital
  • Hoso Naoko
    Department of Pharmacy, Organization of Occupational Health and Safety Wakayama Rosai Hospital
  • Nakatani Ryosuke
    Department of Pharmacy, Japanese Red Cross Tokushima Hospital
  • Sakaguchi Rin
    Department of Hematology, Organization of Occupational Health and Safety Wakayama Rosai Hospital
  • Shimokawa Fukuko
    Department of Pharmacy, Organization of Occupational Health and Safety Wakayama Rosai Hospital

Bibliographic Information

Other Title
  • 担がん患者における化学療法に対するCOVID-19の影響について

Search this article

Description

<p>When a patient with cancer becomes infected with COVID-19, disease progression occurs due to the disease becoming more severe or treatment for the underlying disease being interrupted. We investigated the outcome of COVID-19 in cancer patients and the influence on the effect of chemotherapy. The subjects were 45 patients with COVID-19 among 258 cancer patients who were hospitalized and underwent chemotherapy from January 2022 to February 2023.</p> <p>The incidence rate of COVID-19 for each cancer type was 26.8％ for blood cancer, 25.0％ for lung cancer, and 11.0％ for other cancers, with blood cancer and lung cancer significantly higher than other cancers. In addition, the median number of days required for Ct value ≥ 35 was 43.5 days in blood cancer patients, which was significantly longer than in lung cancer patients and other cancer patients. Of the 45 patients infected with COVID-19, 28 patients were infected during chemotherapy, and the median time from chemotherapy to infection with COVID-19 was 14 days. Twenty patients postponed chemotherapy, and the median number of postponed days was 20 days. Death within 30 days of infection with COVID-19 was observed in 2 cases of hematological cancer, 1 of which was due to exacerbation of the primary disease due to the postponement of chemotherapy. This study suggests that COVID-19 may affect the disease prognosis of cancer patients.</p>

Journal

References(19)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top